Picture of Agile Therapeutics logo

AGRX — Agile Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Agile Therapeutics slumps on stock, warrants deal

** Agile Therapeutics  AGRX.O  shares down >25% premarket
after co prices follow-on
    ** Co sells 26.7 mln shares and warrants to buy 13.3 mln
shares at combined price of 85 cents/sh, raises ~$22.7 mln
 urn:newsml:reuters.com:*:nGNX56ghxy
    ** 5-yr warrants have exercise price of 85 cents, can be
exercised immediately
    ** AGRX has 93 mln shares outstanding and 72.4 mln of public
float, per Refinitiv data
    ** Oppenheimer sole book-running manager for offering
    ** Stock has lost 67% of its value in 2021

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))

Recent news on Agile Therapeutics

See all news